OSHA Regulation 29 CFR 1910.1030: Summary of Key Provisions
Limits occupational exposure to blood and other potentially infectious materials since any exposure could result in transmission of bloodborne pathogens which could lead to disease or death.
Please use the following links to navigate through this OSHA Regulation:
- Exposure Control Plan
- Methods of Compliance
- HIV and HBV Research Laboratories and Production Facilities
- Hepatitis B Vaccination
- Post-exposure Evaluation and Follow-up
- Hazard Communication
- Information and Training
- View Entire Summary
Post-exposure Evaluation and Follow-up
Specifies procedures to be made available to all employees who have had an exposure incident plus any laboratory tests must be conducted by an accredited laboratory at no cost to the employee. Follow-up must include a confidential medical evaluation documenting the circumstances of exposure, identifying and testing the source individual if feasible, testing the exposed employee's blood if he/she consents, post-exposure prophylaxis, counseling and evaluation of reported illnesses. Healthcare professionals must be provided specified information to facilitate the evaluation and their written opinion on the need for hepatitis B vaccination following the exposure. Information such as the employee's ability to receive the hepatitis B vaccine must be supplied to the employer. All diagnoses must remain confidential.